NASDAQ:MBRX
Moleculin Biotech, Inc.
- Stock
Last Close
5.07
17/05 20:00
Market Cap
16.24M
Beta: 2.00
Volume Today
8.36K
Avg: 244.71K
PE Ratio
−0.62
PFCF: −0.65
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
revenue | |||||||||
cost of revenue | 185K - | 285K 54.05% | 260K 8.77% | 222K 14.62% | 127K 42.79% | ||||
gross profit | -185K - | -285K 54.05% | -260K 8.77% | -222K 14.62% | -127K 42.79% | ||||
selling and marketing expenses | |||||||||
general and administrative expenses | 2.38M - | 4.09M 71.75% | 5.30M 29.51% | 6.31M 19.16% | 6.79M 7.49% | 8.39M 23.60% | 11.67M 39.18% | 10.02M 14.18% | |
selling general and administrative expenses | 2.38M - | 4.09M 71.75% | 5.30M 29.51% | 6.31M 19.16% | 6.79M 7.49% | 8.39M 23.60% | 11.67M 39.18% | 10.02M 14.18% | |
research and development expenses | 1.50M - | 4.54M 203.90% | 9.73M 114.04% | 11.01M 13.21% | 12.76M 15.84% | 14.42M 13.02% | 18.97M 31.56% | 19.49M 2.74% | |
other expenses | 6.16K - | 18K 192.11% | -40K 322.22% | 199K 597.50% | 200K 0.50% | 164K 18% | 40K 75.61% | 127K 217.50% | |
cost and expenses | 3.88M - | 8.65M 122.83% | 15.03M 73.64% | 17.52M 16.63% | 19.74M 12.66% | 22.97M 16.34% | 30.64M 33.40% | 29.63M 3.29% | |
operating expenses | 3.88M - | 8.65M 122.83% | 15.03M 73.64% | 17.52M 16.63% | 19.74M 12.66% | 22.97M 16.34% | 30.64M 33.40% | 29.50M 3.71% | |
interest expense | 43.21K - | -1.61M - | |||||||
ebitda | -3.88M - | -7.48M 93.01% | -18.21M 143.35% | -21.39M 17.45% | -21.89M 2.34% | -29.53M 34.92% | -31.98M 8.27% | -29.50M 7.73% | |
operating income | -3.88M - | -8.65M 122.83% | -15.03M 73.64% | -17.52M 16.63% | -19.74M 12.66% | -22.97M 16.34% | -30.64M 33.40% | -29.63M 3.29% | |
depreciation and amortization | 6.16K - | 18K 192.11% | 68K 277.78% | -3.86M 5,780.88% | -2.15M 44.45% | -6.56M 205.87% | -1.33M 79.66% | 127K 109.51% | |
total other income expenses net | -43.21K - | -1.15M 2,565.80% | 3.15M 373.00% | 4.09M 30.05% | 2.39M 41.64% | 7.07M 196.36% | 1.61M 77.17% | -138K 108.54% | |
income before tax | -3.93M - | -9.80M 149.72% | -11.88M 21.12% | -13.43M 13.12% | -17.36M 29.19% | -15.89M 8.42% | -29.02M 82.62% | -29.77M 2.56% | |
income tax expense | 1.15M - | 3.15M 173.00% | -229K 107.28% | -2.36M 930.13% | -7.03M 198.18% | -1.61M 77.04% | |||
net income | -3.93M - | -9.80M 149.72% | -11.88M 21.12% | -13.21M 11.19% | -15.00M 13.56% | -8.86M 40.92% | -27.41M 209.37% | -29.77M 8.61% | |
weighted average shs out | 1.64M - | 3.09M 88.95% | 4.32M 39.50% | 452.46K 89.52% | 656.38K 45.07% | 1.79M 172.97% | 1.91M 6.43% | 1.98M 3.60% | |
weighted average shs out dil | 1.64M - | 3.09M 88.95% | 4.32M 39.50% | 452.46K 89.52% | 656.38K 45.07% | 1.79M 172.97% | 1.91M 6.43% | 1.98M 3.60% | |
eps | -2.40 - | -3.17 32.08% | -2.75 13.25% | -29.18 961.09% | -22.85 21.69% | -4.94 78.38% | -14.37 190.89% | -15.07 4.87% | |
epsdiluted | -2.40 - | -3.17 32.08% | -2.75 13.25% | -29.18 961.09% | -22.85 21.69% | -4.94 78.38% | -14.37 190.89% | -15.07 4.87% |
All numbers in USD (except ratios and percentages)